DUBLIN–(BUSINESS WIRE)–The “Cancer Immunotherapy Market by Product, Distribution Channel, Application, End Use, and by Region – Global Forecast to 2022-2033” report has been added to ResearchAndMarkets.com’s offering.
The cancer immunotherapy market size is estimated to be USD 110,125.4 million in 2022 and is expected to witness a CAGR of 7.51% during the forecast period 2023-2033.
Companies Mentioned:
Surge in oncology incidence around the world and spike in R&D efforts for the creation of novel oncology treatments are factors contributing to the market growth.
Additionally, rise in funds for the development of innovative therapies and various strategic measures implemented by top companies is supporting the market growth. However, immunotherapy adverse effects are expected to hinder the growth.
Rise in funds for the development of innovative therapies is expected to propel the market growth during the projected period. For instance, the U.S. National Cancer Institute and Cancer Research UK’s Cancer Grand Challenges project provided USD 13 million in funding to a team of Stanford scientists in June 2022. The creation of new immunotherapies, research into extrachromosomal DNA, and analysis of early-stage cancers are all recipients of this funding.
Various strategic measures implemented by top companies is predicted to fuel the market growth during the forecast period. For instance, in August 2022, Genmab A/S and BioNTech SE strengthened their strategic partnership for the creation and introduction of novel immune treatments for the management of various cancer types.
Additionally, Merck & Co., Inc. announced in March 2022 that the US FDA has approved KEYTRUDA. An anti-PD-1 therapy named KEYTRUDA is used to treat advanced endometrial cancer.
Market Segmentation
Product (Revenue, USD Million), 2022 – 2033
Distribution Channel (Revenue, USD Million), 2022 – 2033
Application (Revenue, USD Million), 2022 – 2033
End Use (Revenue, USD Million), 2022 – 2033
By Region (Revenue, USD Million), 2022 – 2033
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/6ag9at
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
This groundbreaking partnership expands access to one of dentistry’s most advanced dental artificial intelligence technology…
DUBLIN--(BUSINESS WIRE)--The "Flat Glass - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.…
SINGAPORE--(BUSINESS WIRE)--Mobvista (1860.HK), a leading global marketing and advertising technology company, has today released its…
A bread revolution across the world begins now! TOKYO--(BUSINESS WIRE)--#Aeruta--Do you love bread and sweets?…
PORTSMOUTH, United Kingdom--(BUSINESS WIRE)--#ICPC--The International Cable Protection Committee (ICPC), the world’s leading organisation promoting submarine…
Continued international expansion in the Asian market alongside Enhance Gourmet Foods, a specialist in vegan…
